Navigation Links
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Date:12/7/2009

THOUSAND OAKS, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that its board of directors has authorized repurchases of up to an additional $5 billion in Amgen common stock. The company currently has approximately $1.2 billion remaining under its previous stock repurchase authorization. This new authorization reflects Amgen's confidence in its long-term prospects.

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2008, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from t
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
10. Call for Applications: The Amgen Award for Science Teaching Excellence
11. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 /CNW Telbec/ - Russell Williams , President ... (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the fiscal ... the biopharmaceutical industry. However, the association is concerned about ... commend the government,s intent to strive for a balanced ... promote Quebec,s economic development is ...
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in ... on top as the country,s manufacturing leader in innovation ... ndp│analytics. According to the  analysis , the industry had ... last decade, accounting for 27 percent of average annual ... Short Video on Medicare Part D - Medicare ...
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today announced it ... South First St. in the Temple Medical and Education District ... of Temple to receive funding for redevelopment. Located ... Health Care System, the new facility will enable THBD to ... life science companies. Temple ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... of Sexual Medicine INDIANAPOLIS, May 6 Eli Lilly ... results from a double-blind, placebo-controlled study which showed that ... well-tolerated, improved erectile function for men with erectile dysfunction ... life scores for men and their female partners. The ...
... 6 D-Pharm announced today that it,has submitted IND ... and Drug Administration (FDA), for its pivotal Phase III ... plans to initiate the,trial later this year following FDA ... Scientific Advice from the European Medicines Agency,(EMEA) on the ...
Cached Medicine Technology:Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 2Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 3Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 4Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 5D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3
(Date:3/28/2015)... Mirada, CA (PRWEB) March 28, 2015 ... ear, nose and throat disorders, are now ... is a common issue which is characterized by the ... Affecting 1 in 5 people, tinnitus is a prevalent ... disorder and while it is non-fatal, tinnitus can impede ...
(Date:3/28/2015)... March 28, 2015 ARDX will sponsor the ... 12pm -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... an empowering event for women in the Hampton Roads region. ... Stories of Women’s Lives. Women grow stronger through sharing ... other. This year the WWC™ theme is T-talk where ...
(Date:3/28/2015)... LTW Cyber is an innovation hub for ... purpose of addressing the needs of the global market ... opportunities to grow while seeking collaborative opportunities with the ... Ventures in LTW Cyber focus on secure application security, ... vulnerabilities and analyzing open source. As the hub ...
(Date:3/27/2015)... Deer, Alberta (PRWEB) March 27, 2015 In ... until then, prevented her from working, Monica K. arrived at ... in the mending department quiet, defensive and scared. The owners ... Placement & Support Services (EPSS) to offer jobs to ... does take patience and a willingness to begin with the ...
(Date:3/27/2015)... Lewisville, Texas (PRWEB) March 27, 2015 ... at 7am today. The new facility is located 12665 W ... , “As a resident of Summerwood, I look forward to ... here,” said Dr. Sowell, Facility Medical Director of First Choice ... First Choice Emergency Room made a donation to Summer Creek ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... of Dimes and Kmart--Working Together for Stronger, Healthier,Babies, ... premature birth rises in the U.S., Kmart,s partnership with ... Kmart,s associates and customers,have raised an unprecedented $71 million ... This year, Kmart,s 2008 March for Babies,campaign topped the ...
... Efforts Oppose $6.5 Million Funding Cut to State,s ... The Arkansas,Health Care Association and the American Health ... and Mark Pryor (D) and,Representatives Marion Berry (D-1st), ... (D-4th) for helping lead efforts in the U.S. ...
... the 1 in 8 Hispanics with type 2 disease , , ... of the most serious health issues facing Hispanics in the ... diabetes has been released. , The Agency for Healthcare Research ... 2 , a consumer guide aimed at the estimated one ...
... From Various Pro Teams During Each Tour ... Stage, LAKE SUCCESS, N.Y., July 2 , WHO: ... assessment technology, WHAT: Micro-site ... various pro cyclists during every stage of the Tour de France. ...
... Inc., the,highly respected developer and manufacturer of proprietary ... Stable Liquid L-Ascorbic Acid,(Vitamin C), has terminated the ... right to exclusively market the proprietary,product formulas of ... IS Clinical termination was triggered by that company,s,introduction ...
... rises in caesarean section rates, according to a paper ... The findings come from an analysis of a large ... Professor Gordon Smith, at the University,s Department of Obstetrics ... 500,000 entries collected by the Scottish Morbidity Record between ...
Cached Medicine News:Health News:4 Million Babies Born Each Year in United States; $8 Million That Shows You Care About All of Them! 2Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 2Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 3Health News:New Spanish Consumer Guide Compares Diabetes Meds 2Health News:Polar to Feature Live Tour de France Race Data 2Health News:Termination of IS Clinical From Distributing PhytoCeuticals Formulas 2Health News:Major rise in Caesarean sections linked to impaired womb function with age 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: